<DOC>
	<DOCNO>NCT01663805</DOCNO>
	<brief_summary>This open , randomize , single-center study . The selected patient first divide two major group accord type organ transplant : standard criterion donor ( SCD ) extend criterion ( ECD ) kidney . Then , group randomly allocate one treatment : tacrolimus ( TAC ) everolimus ( EVL ) . All patient receive induction therapy basiliximab ( BXB ) maintenance Mycophenolate Sodium ( MYF ) prednisone ( P ) . This study evaluate Primary objective : To characterize molecular profile cytokine kidney obtain deceased donor `` standard '' ( SCD ) extend criterion ( ECD ) biopsies take transplantation evaluate effect treatment everolimus ( EVL ) expression molecule . And Secondaries objective : To correlate pattern cytokine delay graft function ( DGF ) , cold ischemia time , episode acute rejection patient graft survival .</brief_summary>
	<brief_title>Effects Use `` de Novo '' Everolimus Renal Tranplant Population</brief_title>
	<detailed_description>A total 80 patient participate study , distribute 4 group 20 individual . In pilot study assess interventional effect mmediate use EVL cytokine profile ECD SCD kidney , compare conventional immunosuppressive therapy TAC , statistical power analysis could perform priori . Definitions Extended Criteria Donor Delayed Graft Function ( DGF ) Deceased donor age ≥ 60 year age 50 59 year least two follow risk factor : history systemic hypertension terminal creatinine level &gt; 1.5 mg/dL death cerebrovascular accident . DGF ( delay graft function ) define need dialysis first 7 day transplantation .</detailed_description>
	<mesh_term>Delayed Graft Function</mesh_term>
	<mesh_term>Everolimus</mesh_term>
	<mesh_term>Sirolimus</mesh_term>
	<criteria>Age ≥ 18 year ( black white subject ) ; Endstage renal disease indication transplantation ( primary deceaseddonor kidney transplant ) `` Standard '' traditional ( SCD ) extend criterion ( ECD ) donor ; Informed consent form duly sign SCD ECD kidney transplantation . Exclusion criterion : The subject , opinion investigator , able complete study protocol ; Recipient livedonor kidney graft ; Multiple organ transplant recipient ; Evidence large systemic localized infection ; Evidence infiltration , cavitation consolidation chest Xrays obtain evaluation screen / baseline visit ; Use drug investigation treatment 4 week transplantation ; Known suspect hypersensitivity tacrolimus , everolimus mycophenolate sodium ; Immunosuppressive therapy addition describe study ; Hypersensitized patient ( PRA &gt; 30 % ) ; Patients HIV+ Hepatitis B C virus infection . Patients T0 T15 biopsies take .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>April 2012</verification_date>
	<keyword>Extended Criteria Donor</keyword>
	<keyword>Delayed Graft Function</keyword>
	<keyword>DGF</keyword>
	<keyword>Deceased donor age ≥ 60 year</keyword>
	<keyword>age 50 59 year</keyword>
	<keyword>history systemic hypertension</keyword>
	<keyword>terminal creatinine level &gt; 1.5 mg/dL</keyword>
	<keyword>death cerebrovascular accident</keyword>
</DOC>